Cypherpunk Technologies Inc. (CYPH): Total Assets
$163.18M
As of 2025-12-31
$142.97M
As of 2026-06-30
+32.4%
3-year compound annual growth
+24.6%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $163.18M | +232.2% | 2026-03-16, Balance as of period end |
| 2024-12-31 | $49.12M | -32.5% | 2026-03-16, Balance as of period end |
| 2023-12-31 | $72.83M | +3.5% | 2025-03-26, Balance as of period end |
| 2022-12-31 | $70.35M | -40.3% | 2024-03-18, Balance as of period end |
| 2021-12-31 | $117.91M | +116.9% | 2023-03-24, Balance as of period end |
| 2020-12-31 | $54.37M | +630.0% | 2022-03-11, Balance as of period end |
| 2019-12-31 | $7.45M | -61.0% | 2021-03-12, Balance as of period end |
| 2018-12-31 | $19.07M | -34.4% | 2020-03-16, Balance as of period end |
| 2017-12-31 | $29.06M | +350.1% | 2019-04-01, Balance as of period end |
| 2016-12-31 | $6.46M | n/a | 2018-02-23, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Cypherpunk Technologies Inc. (CYPH) | 2025-12-31 | $163.18M | +232.2% |
| Transcode Therapeutics, Inc. (RNAZ) | 2025-12-31 | $162.40M | n/m |
| Apimeds Pharmaceuticals US, Inc. (APUS) | 2025-12-31 | $164.18M | n/m |
| Aclaris Therapeutics, Inc. (ACRS) | 2025-12-31 | $160.46M | -27.2% |
| Aquestive Therapeutics, Inc. (AQST) | 2025-12-31 | $160.43M | +58.2% |
| Gyre Therapeutics, Inc. (GYRE) | 2025-12-31 | $166.13M | +32.5% |
| Climb Bio, Inc. (CLYM) | 2025-12-31 | $167.74M | -22.8% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | 2025-12-31 | $168.19M | +7.9% |
| Eledon Pharmaceuticals, Inc. (ELDN) | 2025-12-31 | $169.01M | -4.7% |
Compare CYPH, RNAZ, APUS, ACRS side by side · Screen every company in Pharmaceutical Preparations ↗